Financial Architects, Inc Exact Sciences Corp Call Options Transaction History

Financial Architects, Inc

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2019 May 13, 2019	BUY	$61.98 - $96.5 $30,990 - $48,250	500 New	500 $43,000
Q1 2019 May 03, 2019	SELL	$61.98 - $96.5 $185,940 - $289,500	-3,000 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$56.04 - $82.66 $112,080 - $165,320	2,000 Added 200.0%	3,000 $189,000
Q3 2018 Oct 29, 2018	BUY	$48.29 - $80.6 $48,290 - $80,600	1,000 New	1,000 $79,000

676

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.